21st Century Cures Act

Glioblastoma is a rare type of brain cancer thrust into the spotlight after it was reported Sen. John McCain has been diagnosed with the very aggressive disease. Glioblastoma affects 15,000–17,000 new patients in the United States every year, and treatment options haven’t changed much...

Egalet Corp (NASDAQ: EGLT) was surely one of the most watched biotechs of the fourth quarter of 2016. After the company announced the Food and Drug Administration would miss its PDUFA decision date for Egalet’s opioid-based pain medication ARYMO ER, investors waited impatiently for news of a...

KeyBanc Capital’s Donald Hooker expects the Investor Summit hosted by athenahealth, Inc (NASDAQ: ATHN) on December 15 to include discussions on two “promising” verticals, hospitals and population health management. Hooker maintains a Sector Weight rating on the company....

Congressional Republicans and Democrats joined forces on Thursday to pass the 21st Century Cures Act, a comprehensive piece of healthcare legislation that provides funding for researching some of America’s biggest health concerns. Senate Vote 94–5 The legislation passed a Senate vote 94...

Last week, the House Energy and Commerce Committee unanimously passed the 21st Century Cures Act, a new bill that will help fund medical research and relax regulations related to the discovery, development and delivery of new drugs. While some consider the new bill as a major step forward for the...